Implementation of Novel Lipid Therapies in a Refractory Heterozygous Familial Hypercholesterolemia Patient With Atherosclerotic Disease

Compound heterozygous familial hypercholesterolemia patients are phenotypically similar to homozygous familial hypercholesterolemia patients, present with significant elevations of low-density lipoprotein cholesterol, and are at risk of cardiovascular disease. Although new treatment options are emer...

Descripción completa

Detalles Bibliográficos
Autores principales: Weintraub, Spencer F., Schillow, Jessica A., Azari, Bani M., Hirsh, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588451/
https://www.ncbi.nlm.nih.gov/pubmed/36299643
http://dx.doi.org/10.1016/j.jaccas.2022.06.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588451/
https://www.ncbi.nlm.nih.gov/pubmed/36299643
http://dx.doi.org/10.1016/j.jaccas.2022.06.021

Ejemplares similares